AlphaStocks
3.4
Weak

CVS HEALTH Corp (CVS)

Health Care / Health Care Services

S&P 500

$86.86

Scores poorly across most models. Proceed with caution.

Weak

Score based on 5 of 5 models — high confidence

#952out of 1126 in Health Care

Is CVS HEALTH Corp a Good Investment in 2026?

CVS HEALTH Corp (CVS) scores 3.4 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates CVS HEALTH Corp as Attractive (6/9). However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 83%). CVS HEALTH Corp currently trades above its estimated fair value of $50, suggesting limited upside at current prices. CVS HEALTH Corp ranks #952 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E62.4ROE2.4Market Cap111BDiv Yield3.3

Estimated Fair Value

$50.0374% above

Trading above estimated fair value. P/e of 62x implies high growth expectations. eps growth of -62% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

87% above fair value

Lynch

Caution

High PEG — growth premium · Slow Grower

Greenblatt

Caution

Bottom half (rank 83%)

Frequently Asked Questions

Is CVS HEALTH Corp (CVS) a good investment?
Based on AlphaStocks' composite analysis, CVS HEALTH Corp (CVS) scores 3.4 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading above estimated fair value. P/e of 62x implies high growth expectations. eps growth of -62% may not justify the premium.
What is CVS HEALTH Corp's Piotroski F-Score?
CVS HEALTH Corp's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CVS overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $50, CVS appears overvalued. The stock currently trades 74% above its estimated fair value. Trading above estimated fair value. P/e of 62x implies high growth expectations. eps growth of -62% may not justify the premium.
How does CVS compare to other Health Care stocks?
CVS HEALTH Corp ranks #952 out of 1126 stocks in the Health Care sector, placing it in the top 85% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about CVS?
AlphaStocks evaluates CVS using five proven investment models. Piotroski: Attractive; Buffett: Caution; Graham: Neutral; Lynch: Caution; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 3.4/10.

Similar Stocks

PARRAZNFTI

Compare CVS with

CVS vs PARRCVS vs AZNCVS vs FTI

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer